PuraCath Medical
  • Home
  • About Us
    • PuraCath
    • Management Team
    • Board of Directors
    • Advisory Board Members
  • Technology
  • Patients
    • Peritoneal Dialysis
    • Vascular Access
  • Events
  • News
  • Contact
  • Search
PuraCath-Website-New-Title-Bar-with-one-swoosh

News

Why We Aren’t Using UV to Disinfect Everything—Yet

June 16, 2020/in News /by puracath

Negative perception and costs pose obstacles to a promising technology As the coronavirus pandemic continues, a technology that has existed for over 100 years is getting renewed attention as a promising disinfection tool. Ultraviolet germicidal radiation, which uses short-wavelength UV rays to kill bacteria and viruses, is already used to disinfect the air, water, and […]

Read more →

PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second

April 27, 2020/in News /by puracath

PuraCath has been partnered and working with a top tier BSL-3 National Laboratory, which has a premiere high containment infectious disease facilities to test its Firefly UV device for the ICU and hospitals with 2019-nCoV (the COVID-19 virus). The preliminary results show that PuraCath’s device has achieved 99.9999% disinfection with SARS-CoV-2 (the virus that is […]

Read more →

PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2

March 19, 2020/in News /by puracath

President Trump has officially declared a national emergency. A novel coronavirus has been identified in Wuhan City, China and has spread worldwide. It has been named SARS CoV-2 (causing disease COVID-19) by WHO. SARS CoV-2 has officially become a global pandemic by WHO. There have already been over 170,000 confirmed cases to date with an […]

Read more →

PuraCath Medical Shows Greater Than 99.99% Reduction in ‘Superbug’ Candida Auris with One Second of UVC Exposure

June 19, 2019/in News /by puracath

JUNE 18, 2019 PuraCath Medical, a venture-backed medical device company based in Silicon Valley, announced today that it has achieved 99.99% disinfection on its vascular access Firefly disinfection technology system with Candida auris (‘superbug’), Staphylococcus aureus, and Candida albicans. “Achieving greater than 4 log disinfection in these virulent microbes with only one second of UV […]

Read more →

PuraCath Medical Shows Significant Reduction in Causes of Peritonitis in Peritoneal Dialysis International Journal

March 7, 2017/in News /by puracath

San Francisco, California (March 7, 2017) – PuraCath Medical has published the result of its recent research on its ultraviolet (UV) light-based peritoneal dialysis catheter connection system in Peritoneal Dialysis International (PDI), the official Journal of the International Society for Peritoneal Dialysis. PDI is a major source of knowledge in the field of peritoneal dialysis and aims […]

Read more →

PuraCath Medical to Present Data on FireFly™ Peritoneal Dialysis Connector Disinfecting System during 53rd ERA-EDTA Congress

May 12, 2016/in News /by Larry Yost

San Francisco, California (May 12, 2016) – Data being presented will support planned introduction of PuraCath Medical’s technology in the European Union. PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it will present data on its next generation version of the FireFly™ […]

Read more →

PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings

April 28, 2016/in News /by Larry Yost

Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held […]

Read more →

PuraCath Medical Presents New Research Data during 36th Annual Dialysis Conference

February 29, 2016/in News /by Larry Yost

Company presents study on the effectiveness of next-generation version of the FireFly™ Peritoneal Dialysis Connector Disinfecting System Seattle, Washington (February 29, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of […]

Read more →

PuraCath Medical Receives 510(k) Clearance for the FireFly™ Peritoneal Dialysis Connector Disinfecting System

January 26, 2016/in News /by puracath

PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it has received 510(k) clearance for its FireFly™ Peritoneal Dialysis Connector Disinfecting System from the U.S. Food and Drug Administration (FDA). This regulatory determination by the FDA gives PuraCath clearance to market […]

Read more →

The MedTech Strategist: PuraCath Medical, Anti-infection Device Enables Greater Access to Peritoneal Dialysis

October 22, 2015/in News /by puracath

We are excited to announce that PuraCath Medical is listed as a start-up to watch in the latest volume of the MedTech Strategist published on October 16th.  Please read the full article here.

Read more →

PuraCath Medical Presents Data on the Company’s Proprietary Infection Reduction Technology during the National Science Foundation’s SBIR Phase II Grantee Conference

June 2, 2015/in News /by puracath

Atlanta, Georgia (June 2, 2015) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients on dialysis therapy, announced today that the company was a featured presenter during the National Science Foundation’s (NSF) Small Business Innovation Research (SBIR) 2015 Phase II Grantee Conference held in Atlanta, Georgia. PuraCath presented […]

Read more →

PuraCath Medical Presents Study at National Kidney Foundation 2015 Spring Clinical Meetings

March 27, 2015/in News /by puracath

Company presents new data on the effectiveness of UV light to purify peritoneal dialysis catheter connections across a wider range of microorganisms that contribute to infections in PD patients Dallas, Texas (March 27, 2015) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, […]

Read more →

PuraCath Medical Presents Data at 2014 Annual Meeting of the American Society of Nephrology

November 14, 2014/in News /by puracath

Company presents study on the effectiveness of UV light to purify peritoneal dialysis catheter connections PuraCath Medical, an emerging company in the development of technologies to reduce infections in dialysis patients, announced today that it presented scientific data during Kidney Week 2014 demonstrating the ability to reduce bacterial growth in a simulated peritoneal dialysis delivery […]

Read more →

KHI stakeholders conference 2014 – June 11-12, 2014

June 27, 2014/in News /by puracath

To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.

Read more →

PuraCath Medical presents with booth at BIO 2014 conference under SBIR Innovation Zone

June 25, 2014/in News /by puracath

The 2014 BIO International Convention is June 23-26 at the San Diego Convention Center in San Diego, California. BIO 2014 conference under SBIR Innovation Zone

Read more →

PuraCath Medical, Inc. Awarded NSF Grant

January 14, 2012/in News /by puracath

PuraCath Medical, Inc. Awarded NSF (National Science Foundation) SBIR Phase I Grant for Developing Innovative Catheter Design for PD Patients.

Read more →

PuraCath Medical, Inc. Awarded NSF SBIR Phase II Grant

December 28, 2010/in News /by puracath

PuraCath Medical, Inc. Awarded NSF SBIR Phase II Grant for Novel Peritoneal Dialysis Catheter to Reduce Infections.

Read more →

Recent Posts

  • Why We Aren’t Using UV to Disinfect Everything—Yet
  • PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second
  • PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2
  • PuraCath Medical Shows Greater Than 99.99% Reduction in ‘Superbug’ Candida Auris with One Second of UVC Exposure
  • PuraCath Medical Shows Significant Reduction in Causes of Peritonitis in Peritoneal Dialysis International Journal
© Copyright - PuraCath 2017
  • E-Mail Updates
  • Terms of Use
Scroll to top